Therapy News and Research

RSS

FDA issues emergency use authorization for convalescent plasma in COVID-19

The FDA said that based on the scientific evidence available, it had released a decision memorandum that convalescent plasma may be useful in treating COVID-19 in hospitalized patients, and the known potential benefits of use outweigh the risks.

24 Aug 2020

Developing more precise, targeted therapy for a highly aggressive breast cancer

Taking advantage of a cancer cell's altered metabolism that drives its runaway growth, Princess Margaret researchers are zeroing in on these molecular changes to help them develop more precise drug targets for one of the most deadly breast cancers.

21 Aug 2020

New injectable drug could offer long-lasting protection from HIV with fewer side effects

Scientists have developed an injectable drug that blocks HIV from entering cells. They say the new drug potentially offers long-lasting protection from the infection with fewer side effects.

21 Aug 2020

Harvard's Wyss Institute launches Torus Biosystems to develop, commercialize DNA nanotechnology

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.

21 Aug 2020

Key molecule can be used to assess prognosis of triple negative breast cancer

Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.

21 Aug 2020

Cobra Biologics successfully produced master cell banks for CombiGene’s gene therapy

Cobra Biologics, part of the Cognate BioServices family, an international CDMO manufacturer of biological materials and pharmaceuticals, and CombiGene AB, the leading gene therapy company in the Nordic region, today announced that Cobra has successfully produced master cell banks for the three plasmids used as starting material for CombiGene’s gene therapy CG01.

21 Aug 2020

New York Blood Center receives $15.6 million NIH grant for sickle cell transfusion research

The National Heart, Lung and Blood Institute of the National Institutes of Health has awarded a five-year grant of $15.6 million to Karina Yazdanbakhsh, PhD, of New York Blood Center’s Lindsley F. Kimball Research Institute, to lead a collaborative research program studying the consequences of transfusions in patients with sickle cell disease and developing strategies to optimize transfusion management for this patient group.

21 Aug 2020

Using engineered off-the-shelf therapeutic T cells to fight cancer

Personalized cancer treatments are no longer just options of the future. In the past few years, researchers have made significant progress in 'teaching' the body's immune T cells to recognize and kill specific cancer cells, and human clinical trials have shown that this approach can successfully eliminate tumors.

20 Aug 2020

A metabolic enzyme shows great potential as target for immunotherapies

The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system.

20 Aug 2020

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.

20 Aug 2020

Robotic surgery for oropharyngeal cancer associated with improved health outcomes

Robotic surgery for patients with early stage, oropharyngeal squamous cell cancer is associated with improved health outcomes, including better long-term survival, according to a Cedars-Sinai study published Thursday in JAMA Oncology.

20 Aug 2020

FDA provides update on adverse events associated with breast implants

Today, the U.S. Food and Drug Administration is providing an update on adverse events reported to the Agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and systemic signs and symptoms referred to by patients as breast implant illness (BII), which some patients report after receiving breast implants.

20 Aug 2020

Study may lead to novel therapies for asthma

Researchers identify master regulator genes of asthma, provide new path forward in the study of asthma and the development of novel therapies.

20 Aug 2020

Gastric bypass surgery is the most effective therapy to treat type 2 diabetes

Gastric bypass surgery is the most effective therapy to treat or reverse type 2 diabetes in severely obese patients.

20 Aug 2020

Drug used in rheumatoid arthritis and cancer treatment improves survival in critically ill COVID-19 patients

Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically-ill patients admitted to the intensive care unit (ICU).

20 Aug 2020

HEARTROID PROJECT and TTDD lab at MIT partner to develop innovative devices

HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.

19 Aug 2020

Therapy News and Research

FDA issues emergency use authorization for convalescent plasma in COVID-19

Developing more precise, targeted therapy for a highly aggressive breast cancer

New injectable drug could offer long-lasting protection from HIV with fewer side effects

Harvard's Wyss Institute launches Torus Biosystems to develop, commercialize DNA nanotechnology

Key molecule can be used to assess prognosis of triple negative breast cancer

Cobra Biologics successfully produced master cell banks for CombiGene’s gene therapy

New York Blood Center receives $15.6 million NIH grant for sickle cell transfusion research

Using engineered off-the-shelf therapeutic T cells to fight cancer

A metabolic enzyme shows great potential as target for immunotherapies

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Robotic surgery for oropharyngeal cancer associated with improved health outcomes

FDA provides update on adverse events associated with breast implants

Study may lead to novel therapies for asthma

Gastric bypass surgery is the most effective therapy to treat type 2 diabetes

Drug used in rheumatoid arthritis and cancer treatment improves survival in critically ill COVID-19 patients

HEARTROID PROJECT and TTDD lab at MIT partner to develop innovative devices

Osteoarthritis patients can benefit from a qualified, conservative therapy program

New database could speed the development of gene-targeted therapies for breast cancer

Researchers use heparin to block co-receptor for SARS-CoV-2 infection

Researchers identify drug that improves survival in critically ill COVID-19 patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News